Critical Survey: RYTHM (RYM) and Its Rivals
by Tristan Rich · The Markets DailyRYTHM (NASDAQ:RYM – Get Free Report) is one of 902 publicly-traded companies in the “Pharmaceuticals” industry, but how does it compare to its peers? We will compare RYTHM to similar companies based on the strength of its analyst recommendations, institutional ownership, profitability, risk, valuation, dividends and earnings.
Profitability
This table compares RYTHM and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| RYTHM | -6.20% | -12.57% | -2.60% |
| RYTHM Competitors | -2,319.38% | -223.57% | -16.98% |
Institutional and Insider Ownership
6.0% of RYTHM shares are held by institutional investors. Comparatively, 32.6% of shares of all “Pharmaceuticals” companies are held by institutional investors. 3.5% of RYTHM shares are held by insiders. Comparatively, 14.1% of shares of all “Pharmaceuticals” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Volatility & Risk
RYTHM has a beta of 9.44, indicating that its share price is 844% more volatile than the S&P 500. Comparatively, RYTHM’s peers have a beta of -3.17, indicating that their average share price is 417% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for RYTHM and its peers, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| RYTHM | 1 | 0 | 0 | 0 | 1.00 |
| RYTHM Competitors | 7596 | 13657 | 25475 | 1001 | 2.42 |
As a group, “Pharmaceuticals” companies have a potential upside of 27.64%. Given RYTHM’s peers stronger consensus rating and higher probable upside, analysts clearly believe RYTHM has less favorable growth aspects than its peers.
Earnings & Valuation
This table compares RYTHM and its peers revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| RYTHM | $17.28 million | -$33.26 million | -2.13 |
| RYTHM Competitors | $3.49 billion | $3.13 billion | 547.37 |
RYTHM’s peers have higher revenue and earnings than RYTHM. RYTHM is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Summary
RYTHM peers beat RYTHM on 9 of the 13 factors compared.
About RYTHM
Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.